Home » ABBOTT LABORATORIES 'BUY'
ABBOTT LABORATORIES 'BUY'
Analyst Glenn Novarro of Banc of America Securities reiterates his "buy"
rating on Abbott Laboratories. The target price is set to $49.
Newratings
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May